These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9676592)

  • 21. Comparison of non-selective adrenocorticolysis with mitotane or trilostane for the treatment of dogs with pituitary-dependent hyperadrenocorticism.
    Clemente M; De Andrés PJ; Arenas C; Melián C; Morales M; Pérez-Alenza MD
    Vet Rec; 2007 Dec; 161(24):805-9. PubMed ID: 18083978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Megavoltage irradiation of neoplasms of the nasal and paranasal cavities in 77 dogs.
    Théon AP; Madewell BR; Harb MF; Dungworth DL
    J Am Vet Med Assoc; 1993 May; 202(9):1469-75. PubMed ID: 8496103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of urine protein content in dogs with pituitary-dependent hyperadrenocorticism.
    Hurley KJ; Vaden SL
    J Am Vet Med Assoc; 1998 Feb; 212(3):369-73. PubMed ID: 9470045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma cortisol response to ketoconazole administration in dogs with hyperadrenocorticism.
    Feldman EC; Bruyette DS; Nelson RW; Farver TB
    J Am Vet Med Assoc; 1990 Jul; 197(1):71-8. PubMed ID: 2370223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parapituitary meningioma in a dog with pituitary-dependent hyperadrenocorticism.
    Miller WH
    J Am Vet Med Assoc; 1991 Feb; 198(3):444-6. PubMed ID: 2010339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative study by age and gender of the pituitary adenoma and ACTH and alpha-MSH secretion in dogs with pituitary-dependent hyperadrenocorticism.
    Gallelli MF; Cabrera Blatter MF; Castillo V
    Res Vet Sci; 2010 Feb; 88(1):33-40. PubMed ID: 19683322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiotherapy of brain tumors in dogs.
    Turrel JM; Fike JR; LeCouteur RA; Pflugfelder CM; Borcich JK
    J Am Vet Med Assoc; 1984 Jan; 184(1):82-6. PubMed ID: 6421785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of the urine cortisol: creatinine ratio to monitor treatment response in dogs with pituitary-dependent hyperadrenocorticism.
    Guptill L; Scott-Moncrieff JC; Bottoms G; Glickman L; Johnson M; Glickman N; Nelson R; Bertoy E
    J Am Vet Med Assoc; 1997 Apr; 210(8):1158-61. PubMed ID: 9108922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of a low-dose synthetic adrenocorticotropic hormone stimulation test in clinically normal dogs and dogs with naturally developing hyperadrenocorticism.
    Kerl ME; Peterson ME; Wallace MS; Melián C; Kemppainen RJ
    J Am Vet Med Assoc; 1999 May; 214(10):1497-501. PubMed ID: 10340075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperadrenocorticism caused by bilateral adrenocortical neoplasia in dogs: four cases (1983-1988).
    Ford SL; Feldman EC; Nelson RW
    J Am Vet Med Assoc; 1993 Mar; 202(5):789-92. PubMed ID: 8454518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perianal adenomas and hypertestosteronemia in a spayed bitch with pituitary-dependent hyperadrenocorticism.
    Dow SW; Olson PN; Rosychuk RA; Withrow SJ
    J Am Vet Med Assoc; 1988 May; 192(10):1439-41. PubMed ID: 2839445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of ketoconazole to treat dogs with pituitary-dependent hyperadrenocorticism: 48 cases (1994-2007).
    Lien YH; Huang HP
    J Am Vet Med Assoc; 2008 Dec; 233(12):1896-901. PubMed ID: 19072605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mitotane treatment of 32 dogs with cortisol-secreting adrenocortical neoplasms.
    Kintzer PP; Peterson ME
    J Am Vet Med Assoc; 1994 Jul; 205(1):54-61. PubMed ID: 7928549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medical management of pituitary-dependent hyperadrenocorticism: mitotane versus trilostane.
    Reine NJ
    Clin Tech Small Anim Pract; 2007 Feb; 22(1):18-25. PubMed ID: 17542193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term survival with stereotactic radiotherapy for imaging-diagnosed pituitary tumors in dogs.
    Hansen KS; Zwingenberger AL; Théon AP; Kent MS
    Vet Radiol Ultrasound; 2019 Mar; 60(2):219-232. PubMed ID: 30575174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of twice-daily, low-dose trilostane treatment administered orally in dogs with naturally occurring hyperadrenocorticism.
    Vaughan MA; Feldman EC; Hoar BR; Nelson RW
    J Am Vet Med Assoc; 2008 May; 232(9):1321-8. PubMed ID: 18447776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cortisol, aldosterone, cortisol precursor, androgen and endogenous ACTH concentrations in dogs with pituitary-dependant hyperadrenocorticism treated with trilostane.
    Sieber-Ruckstuhl NS; Boretti FS; Wenger M; Maser-Gluth C; Reusch CE
    Domest Anim Endocrinol; 2006 Jul; 31(1):63-75. PubMed ID: 16233969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pituitary corticotroph macrotumors. Diagnosis and treatment.
    Ihle SL
    Vet Clin North Am Small Anim Pract; 1997 Mar; 27(2):287-97. PubMed ID: 9076908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic factors and patterns of treatment failure in dogs with unresectable differentiated thyroid carcinomas treated with megavoltage irradiation.
    Théon AP; Marks SL; Feldman ES; Griffey S
    J Am Vet Med Assoc; 2000 Jun; 216(11):1775-9. PubMed ID: 10844970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pituitary size alteration and adverse effects of radiation therapy performed in 9 dogs with pituitary-dependent hypercortisolism.
    Sawada H; Mori A; Lee P; Sugihara S; Oda H; Sako T
    Res Vet Sci; 2018 Jun; 118():19-26. PubMed ID: 29339329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.